US
Uma Sinha
Chief Scientific Officer

Uma Sinha insider trades: Eidos Therapeutics (EIDX) stock buys and sales

Chief Scientific Officer, Eidos Therapeutics Last trade Jan 13, 2021 22 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2019
3
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Uma reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 13, 2021EIDX↓ Sell$1.2M
Dec 2, 2020EIDX↓ Sell$450K
Oct 29, 2020EIDX↓ Sell$362K
Oct 1, 2020EIDX↓ Sell$262K
Dec 18, 2019EIDX↓ Sell$774K
Sep 25, 2019EIDX↓ Sell$96K
Jul 25, 2019EIDX↓ Sell$181K
Jul 1, 2019BBIO↑ Buy$238K
May 23, 2019EIDX↓ Sell$136K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Uma Sinha's insider trades

Uma Sinha is Chief Scientific Officer at Eidos Therapeutics (EIDX). Since May 23, 2019, Uma has reported 1 open-market purchase worth $238K and 8 sales worth $3.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (12 filings), option exercises (2 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EIDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.